Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
The Evolving Landscape of ROS1-positive NSCLC
|
Sep 03, 2026 |
|
Prof Zarnie Lwin OAM: Mentorship, Research, and the Future of Lung Cancer Treatment
|
Aug 27, 2026 |
|
Smoking Stigma and Lung Cancer Care in the Screening Era
|
Aug 13, 2026 |
|
Dr. Jazmin Eckhaus: Robotic Innovations and Ethics in Thoracic Surgery
|
Jul 30, 2026 |
|
Immunotherapy in Thoracic Cancers: Applying Broad IO Access Across Thoracic Malignancies
|
Jun 25, 2026 |
|
Immunotherapy in Thoracic Cancers: From Indication-Based to Biology-Driven
|
Jun 18, 2026 |
|
The Evolving Landscape of BRAF-Mutated NSCLC in Australia
|
Jun 04, 2026 |
|
Thymic Cancer: The Lesser-Known Thoracic Tumours
|
May 21, 2026 |
|
A/Prof Surein Arulananda: A Masterclass in Career Growth
|
May 07, 2026 |
|
TOGA ASM 2026: Program Review
|
Apr 16, 2026 |
|
ALK TKI Sequencing in the Australian Landscape
|
Apr 09, 2026 |
|
Professor Michael Millward: Clinical Insights in Lung Cancer Research
|
Feb 26, 2026 |
|
Dr. Megan Sanders: From Science to TOGA Leadership
|
Feb 12, 2026 |
|
Lung Cancer Research: 2025 Year in Review
|
Jan 29, 2026 |
|
New and Emerging Practice Standards in ES-SCLC
|
Dec 11, 2025 |
|
Exploring Lung Cancer Care and Research in New Zealand
|
Nov 27, 2025 |
|
Challenging Ageism: Optimising Lung Cancer Treatment in Older Adults
|
Oct 02, 2025 |
|
Prof. Anna Nowak: A Journey from Oncology Lab to Leadership
|
Sep 18, 2025 |
|
CNS Progression in Lung Cancer: A Practical Conversation on Best Practices
|
Sep 04, 2025 |
|
A/Prof Fiona Hegi Johnson: Navigating Careers and Innovations in Lung Cancer Research
|
Aug 14, 2025 |
|
Prof Shankar Siva: Pushing Boundaries in Radiation Oncology
|
Jul 10, 2025 |
|
The Emerging Role of the Microbiome in Lung Cancer and Immunotherapy Response
|
Jun 19, 2025 |
|
Lessons from Fellowships and building Clinical Trials Units
|
Jun 05, 2025 |
|
Prof Wendy Cooper: Journey of a Thoracic Pathologist
|
May 21, 2025 |
|
Vaccines in Thoracic Oncology: The Next Frontier in Immunotherapy
|
May 08, 2025 |
|
The Role of Liquid Biopsy in Modern Oncology
|
Mar 20, 2025 |
|
Exploring EGFR Exon 20 Insertion Mutations
|
Mar 06, 2025 |
|
From Clinical Research to Leadership: A Conversation with Prof. Michael Boyer
|
Feb 05, 2025 |
|
Introducing Conversations in Lung Cancer Research - Trailer
|
Feb 04, 2025 |
|
Navigating Resistance in ALK-Positive NSCLC Patients on TKI Therapy
|
Dec 12, 2024 |
|
Hit It With Your Best Shot- The Case for IO in Early-Stage NSCLC in a Once in a Lifetime World
|
Dec 02, 2024 |
|
Large-Cell Neuroendocrine Carcinoma of the Lung (LCNEC): Challenges in Diagnosis and Treatment
|
Nov 14, 2024 |
|
Management of Limited-Stage Small Cell Lung Cancer (LS-SCLC)
|
Sep 30, 2024 |
|
NTRK1, 2,3 And Other Rare Mutations In NSCLC
|
Aug 30, 2024 |
|
Decoding Perioperative Immunotherapy In NSCLC
|
Jul 25, 2024 |
|
Access to New Medicines: Which Surrogate Endpoints Matter
|
Jun 19, 2024 |
|
Lung Cancer Nurses: Essential, Beneficial and a Key Link In Lung Cancer Screening
|
Apr 22, 2024 |
|
Underutilisation of Radiotherapy in Lung Cancer Treatment
|
Mar 27, 2024 |
|
Revolutionising Lung Cancer Healthcare with AI: Unlocking the Future
|
Feb 28, 2024 |
|
Antibody Drug Conjugates (ADCs) – An Emerging Treatment Platform in Lung Cancer
|
Dec 15, 2023 |
|
Lung cancer Screening and Moving from Concept to Roll Out
|
Oct 31, 2023 |
|
Early Recovery After Surgery - Guidelines and Multidisciplinary Considerations
|
Oct 06, 2023 |
|
Nature and nurture: lung cancer risk and implications for future screening
|
Aug 10, 2023 |
|
Operability in Stage III NSCLC
|
Jul 04, 2023 |
|
NSCLC and KRAS Mutations
|
Jun 06, 2023 |
|
Treatment Considerations in ALK-Positive NSCLC
|
Apr 21, 2023 |
|
Celebrating Female Leadership in Medical Research
|
Mar 08, 2023 |
|
Brain metastases in NSCLC
|
Feb 23, 2023 |
|
NGS panels in lung cancer
|
Dec 20, 2022 |
|
Lung Cancer Screening and its impact on patient care in Australia
|
Dec 07, 2022 |
|
The Management of Stage III NSCLC
|
Oct 31, 2022 |
|
The Changing Course of Outcomes in Early Stage NSCLC: Surgical and Respiratory Medicine Considerations
|
Oct 12, 2022 |
|
Cardiotoxicity and Radiation Therapy - Considerations for Lung Cancer
|
Sep 01, 2022 |
|
Accelerating Progress in Oncogene-driven Lung Cancer
|
Aug 09, 2022 |
|
Access to Molecular Diagnostics and Treatments Across ANZ: The Past, Present, Future
|
Jul 24, 2022 |
|
Practical smoking cessation advice for health care providers
|
May 30, 2022 |
|
Consider Every Trial as a TeleTrial
|
Apr 30, 2022 |
|
EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer
|
Mar 29, 2022 |
|
The need for a National Clinical Quality Registry in Lung Cancer
|
Feb 22, 2022 |
|
ALK treatment considerations in NSCLC
|
Dec 08, 2021 |
|
Stigma and Nihilism In Lung Cancer : A Call to Action
|
Nov 23, 2021 |
|
Challenging the Lung Cancer Stigma
|
Nov 08, 2021 |
|
The Value of Comprehensive Genomic Profiling in Lung Cancer
|
Oct 17, 2021 |
|
Inflammation And Its Impact On The Development & Treatment Of Lung Cancer
|
Sep 24, 2021 |
|
Optimising Diagnosis & Treatment Pathways For Lung Cancer Patients
|
Jul 30, 2021 |
|
Long Term Survivorship: Thriving with Metastatic Lung Cancer
|
Jun 24, 2021 |
|
Women and Lung Cancer: The Rising Tide
|
May 14, 2021 |
|
Practical Perspectives: Shifting the Needle in Small Cell Lung Canceer
|
Apr 01, 2021 |
|
Lung cancer screening works!
|
Mar 01, 2021 |
|
Dreaming of Better Treatments for Mesothelioma
|
Feb 16, 2021 |
|
Lung Cancer Careers: Preceptorship Reflections
|
Dec 13, 2020 |
|
Cancer won't wait: A Cancer Australia Perspective
|
Nov 25, 2020 |
|
2020 Wrap: Remarkable Progress In Diagnosing & Treating Lung Cancer
|
Nov 18, 2020 |
|
Redefining Survival In Lung Cancer: Meet Alexandra
|
Nov 10, 2020 |
|
Improving Survival In Oncogene Driven Lung Cancer
|
Nov 10, 2020 |